Marketing-authorisation holder · Canada
Fujisawa Pharmaceutical Co, Division of Fujisawa Canada Inc.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADENOCARD LIQ IV 3MG/ML3 mg / ml · Liquid | Adenosine | Canada | Cancelled | 1993 |
| ADENOCARD LIQ IV 3MG/ML (PRE-FILLED SYRINGE)3 mg / ml · Liquid | Adenosine | Canada | Cancelled | 1994 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 0 | 2 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Cardiac therapyCardiovascular system · ATC C01E
Top substances
The active substances in most of its medicines.